MetaLnc9 facilitates lung cancer metastasis via a PGK1-activated AKT/mTOR pathway

T Yu, Y Zhao, Z Hu, J Li, D Chu, J Zhang, Z Li, B Chen… - Cancer research, 2017 - AACR
Long noncoding RNAs (lncRNA) participate in carcinogenesis and tumor progression in
lung cancer. Here, we report the identification of a lncRNA signature associated with …

[PDF][PDF] MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway

T Yu, Y Zhao, Z Hu, J Li, D Chu, J Zhang, Z Li… - Cancer Res, 2017 - researchgate.net
Long noncoding RNAs (lncRNA) participate in carcinogenesis and tumor progression in
lung cancer. Here, we report the identification of a lncRNA signature associated with …

MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway.

T Yu, Y Zhao, Z Hu, J Li, D Chu, J Zhang, Z Li… - Cancer …, 2017 - europepmc.org
MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway

T Yu, Y Zhao, Z Hu, J Li, D Chu, J Zhang… - Cancer …, 2017 - pubmed.ncbi.nlm.nih.gov
Long noncoding RNAs (lncRNA) participate in carcinogenesis and tumor progression in
lung cancer. Here, we report the identification of a lncRNA signature associated with …

MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway.

T Yu, Y Zhao, Z Hu, J Li, D Chu, J Zhang, Z Li… - Cancer …, 2017 - europepmc.org
MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …